Register entry

Chongqing Sintaho Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
6
Live patents
0
Countries
1
Base
China
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Chongqing Sintaho Pharmaceutical Co., Ltd.600 Liuqing Road, Maliuzui Town, Banan District, Chongqing, 401319, China (CHN)Active ingredient (API) manufacture3021637531411246988
Catalogue

Drug listings by form and route

6

6 active NDC listings: 6 bulk ingredient. By marketing category: BULK INGREDIENT 6.

Dosage formNDCs
injection, powder, for solution2
injection, solution2
powder2
RouteNDCs
Labeller name on the listingNDCs
chongqing sintaho pharmaceutical co., ltd.6
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
-Azacitidineinjection, powder, for solution84172-112BULK INGREDIENT
-Docetaxelinjection, solution84172-113BULK INGREDIENT
-Eribulin Mesylateinjection, solution84172-901BULK INGREDIENT
-Paclitaxelinjection, powder, for solution84172-111BULK INGREDIENT
-Semaglutidepowder84172-121BULK INGREDIENT
-Tirzepatidepowder84172-201BULK INGREDIENT
Neighbours

Registered in the same town

11
Compare

Comparable companies in China

Enquiry

Common questions

Is Chongqing Sintaho Pharmaceutical Co., Ltd. FDA approved?
Chongqing Sintaho Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Chongqing Sintaho Pharmaceutical Co., Ltd.'s drugs manufactured?
The FDA register lists Chongqing. Registered operations: active ingredient (API) manufacture.
What drugs does Chongqing Sintaho Pharmaceutical Co., Ltd. make?
6 products are listed under Chongqing Sintaho Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as injection, powder, for solution; injection, solution; powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.